Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) Dividend Yield, History & Forecast

Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 1.29% ($0.41 per share annually (TTM)). The most recent ex-dividend date was December 30, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $42M.

OZEM fund composition

OZEM holds 29 positions, with 65.0% of assets in its ten largest. It charges an expense ratio of 0.59%, and manages $61.4M.

Top 10 holdings

HoldingWeight
NVONovo Nordisk A/S13.94%
LLYEli Lilly & Co12.19%
PFEPfizer Inc6.60%
1093.HKCSPC Pharmaceutical Group Ltd6.49%
VKTXViking Therapeutics Inc4.96%
KLRAKailera Therapeutics Inc4.80%
4519.TChugai Pharmaceutical Co Ltd4.29%
ZEAL.COZealand Pharma A/S4.15%
AMGNAmgen Inc4.11%
AZNAstraZeneca PLC3.46%

Sector allocation

Healthcare99.2%Cash & Others0.7%Financial Services0.1%Technology0.0%

Frequently Asked Questions about Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM)

What is Roundhill Investments - GLP-1 & Weight Loss ETF's dividend yield?
Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) pays a current trailing twelve-month dividend yield of 1.29%, which works out to $0.41 per share annually based on the most recent payout schedule.
When does Roundhill Investments - GLP-1 & Weight Loss ETF pay distributions?
The most recent ex-dividend date was December 30, 2025. The next scheduled dividend payment date is December 31, 2025.
What does Roundhill Investments - GLP-1 & Weight Loss ETF invest in?
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.